These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14572598)

  • 1. Avoiding infliximab in the treatment of Crohn's disease in patients with multiple sclerosis.
    Nanavati SA; Ergun GA; Schwartz JT
    Am J Gastroenterol; 2003 Oct; 98(10):2333-4. PubMed ID: 14572598
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
    Gaertner WB; Decanini A; Mellgren A; Lowry AC; Goldberg SM; Madoff RD; Spencer MP
    Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
    Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
    Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for treatment with infliximab for Crohn's disease.
    Hommes DW; Oldenburg B; van Bodegraven AA; van Hogezand RA; de Jong DJ; Romberg-Camps MJ; van der Woude J; Dijkstra G;
    Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].
    Tilg H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W;
    Z Gastroenterol; 2004 Oct; 42(10):1256-63. PubMed ID: 15508068
    [No Abstract]   [Full Text] [Related]  

  • 9. Duodenopancreatic fistula complicating upper gastrointestinal Crohn's disease: successful treatment with infliximab.
    Pajares JA; Hernández L; Menchén P; Menchén L
    Am J Gastroenterol; 2009 Jul; 104(7):1863-4. PubMed ID: 19436276
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.
    Persoons P; Vermeire S; Demyttenaere K; Fischler B; Vandenberghe J; Van Oudenhove L; Pierik M; Hlavaty T; Van Assche G; Noman M; Rutgeerts P
    Aliment Pharmacol Ther; 2005 Jul; 22(2):101-10. PubMed ID: 16011668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort study.
    Atzeni F; Ardizzone S; Sarzi-Puttini P; Colombo E; Maconi G; De Portu S; Carrabba M; Bianchi Porro G
    Aliment Pharmacol Ther; 2005 Sep; 22(5):453-61. PubMed ID: 16128684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis].
    Minnee RC; Stokkers P; Riemens SC; Hommes DW
    Ned Tijdschr Geneeskd; 2005 Oct; 149(41):2290-5. PubMed ID: 16240855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of luminal and fistulizing Crohn's disease with infliximab.
    Comerford LW; Bickston SJ
    Gastroenterol Clin North Am; 2004 Jun; 33(2):387-406, xi. PubMed ID: 15177545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic vulval Crohn's disease and infliximab: a case report.
    Tritton SM; Whyte L; Fischer G
    J Reprod Med; 2009 Jan; 54(1):41-4. PubMed ID: 19263879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab in the surgical management of complex fistulating anal Crohn's disease.
    Talbot C; Sagar PM; Johnston MJ; Finan PJ; Burke D
    Colorectal Dis; 2005 Mar; 7(2):164-8. PubMed ID: 15720356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.
    Maser EA; Villela R; Silverberg MS; Greenberg GR
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1248-54. PubMed ID: 16931170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab in the management of the extra-intestinal manifestations of Crohn's disease.
    Lawrance IC
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1332-3. PubMed ID: 15482549
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antitumour necrosis factor-alpha therapy on bone turnover in patients with active Crohn's disease: a prospective study.
    Ryan BM; Russel MG; Schurgers L; Wichers M; Sijbrandij J; Stockbrugger RW; Schoon E
    Aliment Pharmacol Ther; 2004 Oct; 20(8):851-7. PubMed ID: 15479356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.